Retifanlimab with bevacizumab and hypofractionated radiotherapy to treat recurrent glioblastoma.

Authors: Nishika Karbhari, Angela Ulrich, Wendy Joyce Sherman, Susan Michelle Geyer, Shannon Patricia Fortin Ensign, Milan G. Chheda, Roy E. Strowd, Michael W. Ruff, Sani Haider Kizilbash, Ugur Sener, Joon H. Uhm, Bryan Neth, Evanthia Galanis, Eric J. Lehrer, William Breen, Elizabeth Yan, Anita Mahajan, Paul D. Brown, Jian Li Campian

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2092

Source: Full article


Abstract

TPS2092